• The 3rd annual E-Cigarette Summit has been confirmed to take place Thursday 12th November at The Royal Society, London

Welcome to The E-Cigarette Summit


The 2014 E-Cigarette Summit was held at The Royal Society on Thursday 13th November and was attended by over 250 individuals from industry, public health and academia.  The presentations from the day can be found on the Resources page.  This website currently contains details of the 2014 programme and speakers.  The E-Cigarette Summit will take place again on Thursday 12th November 2015.  Programme and details will follow shortly.

The E-Cigarette Summit will take place at the Royal Society, London on the 12th November 2015.

The issue of how to regulate and manage the exponential growth of e-cigarettes remains a contentious issue and continues to divide scientists, policy makers and health professionals alike.  The E-Cigarette Summit has established itself as a neutral environment for scientists, policy makers, medical and public health professionals and e-cigarette stakeholders to come together and look at the latest scientific research and evidence available on e-cigarettes and debate their impact in context of health and regulation.

Alongside examining the latest scientific evidence on the safety of e-cigarettes, The E-Cigarette Summit will also address broader debates including evidence on Gateway for children and non-smokers, advertising and marketing, use in public places and the conflicts arising from the tobacco industry’s dual corporate ownership of tobacco harm reduction products and cigarettes.  The role that e-cigarettes could play in ending or extending the smoking epidemic will remain one of the most fiercely fought debates in public health history.

For policy makers/advisors, the weight of making the right decision cannot be underestimated.  From outright bans to higher taxation the way that each country introduces, interprets and implements legislation such as the TPD, including consumer and medical licensing routes, will have far reaching consequences. Setting the regulatory bar at the correct level, will be vital to harnessing the opportunities that e-cigarettes could offer while remaining responsive to a fast moving and emerging market, that neither health professionals nor governments have been involved in creating.

The E-Cigarette Summit will include high level briefings from experts and encourage interaction through panel debates and open floor discussions.  Questions will be explored in a balanced and objective environment allowing attendees to build their knowledge and share their viewpoints. So, are e-cigarettes a backward step in the fight against smoking or the single greatest transformative public health phenomenon? Whichever side of the debate you fall on, this is likely to be one of the most significant public health issues for a generation.

What is at stake?

Smoking is the biggest single cause of preventable death in the developed world, and causes more than 5 million deaths per year with trends suggesting that tobacco use will result in more than 8 million deaths annually by 2030. The devastating effect of long-term smoking cannot be underestimated, with up to half of all lifetime smokers dying from smoking related diseases and many more suffering a seriously compromised quality of life. It is well recognised that the most damaging health impacts are caused by the combustion of tobacco, rather than the consumption of nicotine.

Despite these known risks, tobacco products and cigarettes remain readily available. This fact makes the debate over whether to regulate e-cigarettes more strictly than cigarettes– which are estimated to be between 99% and 95% safer – highly controversial and has divided opinion amongst health campaigners and policy makers.

Who Should Attend?

The E-Cigarette Summit will provide a timely opportunity for all stakeholders to debate and explore the future of e-cigarettes, and will include high-level panel debates from opposing perspectives to ensure a balanced and objective debate.

In particular, this event will be relevant to:

  • Regulators and policy advisors
  • Health providers, health charities and health practitioners
  • Local Authorities and Environmental Health
  • Public health professionals and academics
  • Scientific/research community
  • Medical and health professionals
  • e-cigarette industry stakeholders